14. Panel： Navigating Treatment Decisions• Drs. Del Rivero, Chandrasekharan, Clarke and Mittra
In this panel from the Neuroendocrine Cancer Foundation’s 2026 Virtual Annual Patient Conference, Dr. Jaydira Del Rivero of the National Cancer Institute moderates a discussion on Navigating Treatment Decisions for people living with neuroendocrine tumors. Panelists Dr. Chandrikha Chandrasekharan of MD Anderson Cancer Center, Dr. Callisia Clarke of the Medical College of Wisconsin, and Dr. Erik Mittra of Oregon Health & Science University discuss how treatment decisions are made across specialties, including medical oncology, surgical oncology, and nuclear medicine. The panel explores how clinicians evaluate symptoms, tumor grade, Ki-67, imaging results, somatostatin receptor status, disease burden, surgery, chemotherapy, PRRT, and other treatment options. The discussion also highlights the importance of multidisciplinary tumor boards, center-of-excellence care, patient goals, quality of life, second opinions, patient education, and support from the neuroendocrine cancer community. Learn more about the Neuroendocrine Cancer Foundation and access patient resources at www.NCF.net.
In this panel from the Neuroendocrine Cancer Foundation’s 2026 Virtual Annual Patient Conference, Dr. Jaydira Del Rivero of the National Cancer Institute moderates a discussion on Navigating Treatment Decisions for people living with neuroendocrine tumors. Panelists Dr. Chandrikha Chandrasekharan of MD Anderson Cancer Center, Dr. Callisia Clarke of the Medical College of Wisconsin, and Dr. Erik Mittra of Oregon Health & Science University discuss how treatment decisions are made across specialties, including medical oncology, surgical oncology, and nuclear medicine. The panel explores how clinicians evaluate symptoms, tumor grade, Ki-67, imaging results, somatostatin receptor status, disease burden, surgery, chemotherapy, PRRT, and other treatment options. The discussion also highlights the importance of multidisciplinary tumor boards, center-of-excellence care, patient goals, quality of life, second opinions, patient education, and support from the neuroendocrine cancer community. Learn more about the Neuroendocrine Cancer Foundation and access patient resources at www.NCF.net.